Curi Bio and Battelle Announce Strategic Partnership to Accelerate the Adoption of New Approach Methods in Neuromuscular Pharmacology

Curi Bio and Battelle are collaborating to bring human-relevant neuromuscular junction assays to market, combining advanced 3D tissue models with scalable, regulatory-ready infrastructure. The effort supports industry-wide movement away from animal testing, offering reproducible, cell-based methods that improve data quality and efficiency across drug development and medical countermeasure applications.